Abstract. The hyperparathyroidism characteristic of patients with moderate renal insufficiency could be caused by decreases in the plasma concentration of ionized calcium (Ca"+) evoked by: (a) recurring increases in the plasma concentration ofinorganic phosphorus that may be detectable only in the post-prandial period; (b) a reversible, phosphorus-mediated suppression of renal 25-hydroxyvitamin D-la-hydroxylase that decreases the plasma concentration of 1 ,25-dihydroxyvitamin D (1,25-(OH)2D) enough to decrease both gut absorption and bone resorption of Ca"+; (c) both of these. In a group of eight children with moderate renal insufficiency, mean glomerular filtration rate (GFR) 45±4 (SE) ml/min per 1.73 M2, ages 6-17 yr, we tested these hypotheses by determining the effect of short term (5 d) restriction and supplementation of dietary intake of phosphorus on the plasma concentration of 1,25-(OH)2D, the serum concentrations of immunoreactive parathyroid hormone (iPTH) and phosphorus, and the fractional renal excretion ofphosphorus (FEPi). When boxyl-terminal iPTH (C-iPTH) were greater, 59±9 vs.
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boxyl-terminal iPTH (C-iPTH) were greater, 59±9 vs.
17±3 Aleq/ml, and unchanging; the serum concentration of intact-iPTH was also greater, 198+14 vs. 119±8 pg/ ml. The plasma concentration of 1,25-(OH)2D was lower than that of age-matched controls, 27±3 vs. 36±2 pg/ml (P < 0.01). When dietary phosphorus was restricted to 0.35 g/d, the plasma concentration of 1,25-(OH)2D increased by 60% to a mean value not different from that of normal controls, while serum concentrations of CiPTH and intact-iPTH decreased by 25%, the latter concentration to a mean value not different from that of controls. FEPi decreased from 31 to 9%. When dietary phosphorus was supplemented to 2.4 g/d, the plasma concentration of 1,25-(OH)2D decreased 32%, while those of C-iPTH and intact-iPTH increased by 131 and 45%, respectively; FEPi increased from 27 to 53%. Plasma concentrations of 25-hydroxyvitamin D remained normal and unchanged, and GFR did not change when dietary phosphorus was manipulated.
The data demonstrate that in children with moderate renal insufficiency: (a) A normal dietary intake of phosphorus is attended by a decreased circulating concentration of 1,25-(OH)2D and an increased concentration of iPTH, but not by recurring increases in the serum concentration of phosphorus at any time of the day; (b) Dietary 25 -hydroxyvitamin D3-la-hydroxylase (1-hydroxylase) (5-1 1) . In patients with severe and moderate renal insufficiency, the occurrence of severe (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) and moderate (18) (19) (20) (21) (22) (23) (24) reductions in the plasma concentration of 1,25-(OH)2D presumably reflects a reduction in the renal synthesis of this hormone (25, 26) . In patients or animals with renal insufficiency, such a reduction could reflect a reduced amount of 1-hydroxylase, but could also reflect a reversible suppression ofthe activity of the remaining enzyme (27) (28) (29) (30) , even though the activity of this enzyme is normally stimulated by parathyroid hormone (PTH) (31) (32) (33) , and the circulating level of this hormone is characteristically increased in these patients (21, 22, (34) (35) (36) (37) . In some circumstances, the activity of 1 -hydroxylase and apparent production of 1,25-(OH)2D are not principally determined by PTH, but rather by a suppressive effect of inorganic phosphorus (38) (39) (40) (41) (42) (43) (44) . In patients with either idiopathic hypercalciuria (43) or primary hyperparathyroidism (44) in whom dietary phosphorus was supplemented, the circulating concentration of 1,25-(OH)2D decreased to normal levels even though the serum concentration of immunoreactive PTH (iPTH) increased, and that of phosphorus remained normal and unchanged (43), or it decreased (44). Accordingly, in patients with moderate renal insufficiency in whom the dietary intake and serum concentration of phosphorus are not increased, but in whom the amount of phosphorus processed by the remaining nephrons is greatly increased, a phosphorus-mediated suppression of the activity of 1-hydroxylase might reduce the renal synthesis and hence the plasma concentration of 1,25-(OH)2D, and thereby contribute to the pathogenesis of the hyperparathyroidism ofthese patients (21 To determine whether in the affected children the serum concentrations of calcium, phosphorus, and iPTH and the urinary excretion of phosphorus during the day were different from those of normal children, measurements were made during the day in seven of the eight children with moderate renal insufficiency (on day 3 of the control period) and in five of the healthy children. The healthy children, also studied at the Pediatric Clinical Research Center, received constant whole food diets that provided 1,000 mg ofcalcium and 1,200 mg ofphosphorus per day for 3-5 d. Meals were offered at 0830, 1215, and 1715 in both groups of subjects. Blood samples were obtained via an indwelling venous catheter before each of the meals, at 30, 60, and 120 min after breakfast and lunch, and at 60 and 120 min after dinner for measurement of serum concentrations of creatinine, calcium, phosphorus, and iPTH. Urine was obtained by voluntary voiding at 2-h intervals from 0600 to 2000 to measure the concentrations of creatinine and phosphorus. Water intake was encouraged during the study. 25-OHD2 and 25-OHD3 were assumed to be the same. In normal adult subjects, the plasma concentration of total 25-OHD (25-OHD2 and 25-OHD3) was 24±2 ng/ml (mean±SEM, n = 31).
1,25-(OH)2D. The fraction from the LH-20 chromatography that contained 1,25-(OH)2D was further purified by high-pressure liquid chromatography using two g-porasil columns in series in a solvent system of hexane/isopropanol (9: 1) at a flow rate of 2.0 ml/min. 1,25-(OH)2D was quantitated in duplicate using a competitive protein binding assay modified from those described by Eisman et al. (46) and Shepard et al. (47) . Intestinal cytosol binding protein was obtained from normal vitamin D-adequate chicks. Overall recovery of 1,25-(OH)2D was 70-75%. Intraassay and interassay coefficients of variation were 7.7 and 11.6%, respectively. In normal adult subjects, the plasma concentration of 1,25-(OH)2D was 33±3 pg/ml (n = 15).
Serum concentrations of immunoreactive parathyroid hormone were measured by radioimmunoassay in the laboratory of Dr. Sara Arnaud using two antisera: GP-IM, which has high affinity for the intact hormone and its carboxyl-terminal fragments but low affinity for PTH , and is referred to hereafter as carboxyl-iPTH (C-iPTH), and CH-12M, which has high affinity for the intact hormone, at least a 30-fold lower affinity for PTH , and no affinity for carboxyl-terminal fragments, which is referred to hereafter as intact-iPTH (48) . Serum and urinary concentrations of calcium were measured by atomic absorption spectrophotometry, serum concentrations of phosphorus by a modification of the Fiske-Subbarow method (49) , and urinary phosphorus by auto- analyzer.
Data are presented as group means±SEM. The t test for paired data was used to compare differences between values obtained in subjects studied during control intake and either low or high intakes ofphosphorus. Where the differences observed were not normally distributed, the data were analyzed by means ofthe Wilcoxon signed rank test. The unpaired t test was used for all other group comparisons. Correlation coefficients were calculated by Spearman's rank correlation procedure.
Results
Control conditions. In the eight children with moderate renal insufficiency, the mean plasma concentration of 1,25-(OH)2D was significantly lower than the value in age-matched healthy children (27±3 vs. 36±2 pg/ml, P < 0.01) ( * Number of subjects studied. f Significant change from control value, P < 0.005. §P< 0.01. 1"P < 0.05. ¶ Because the changes induced in iPTH were not normally distributed, the data were analyzed using the Wilcoxon signed rank test. ** P < 0.001. The fractional renal excretion of phosphorus (FEP1) during the daytime was significantly higher in the patients than in the normal controls (Fig. 1) , as was the 24-h FEP, (28±2 vs. 1 + 1%, P < 0.001) ( Table I ).
Phosphorus restriction. When the dietary intake of phos-2000 0800 phorus was restricted for five days in seven children with moderate renal insufficiency, the plasma concentration of 1,25-(OH)2D increased in each patient from a mean of 26±3 to 42±2 d phosphopg/ml (60±1 1%, P < 0.005), the latter value being slightly moderate (though not significantly) higher than that in the healthy children ant whole who ingested normal amounts of phosphorus (Table II, Fig. 2 ). of phosphoPlasma concentrations of 25-OHD did not change significantly. ,sed bars) were
The serum concentration of C-iPTH decreased in six of the lepict mean seven patients; the mean decrease was 19±6 uleq/ml (25±6%, in each ofthe five patients in whom the measurement was made to a mean value not significantly different from that in the controls; the mean decrease was 5 1±11 pglml (25±3%, P < 0.01) (Table II) . The mean fasting serum concentrations of calcium and phosphorus did not change significantly during the period of phosphorus restriction; the serum concentration of magnesium decreased. Both the 24-h total and fractional urinary excretions ofphosphorus decreased rapidly and progressively during the period ofphosphorus restriction. After 2 d ofrestriction, both values had decreased by --55% ofthe control values; after 5 d of restriction, total and fractional excretions of phosphorus had decreased by 75 and 71% of the control values, respectively (Table II) . The total urinary excretion of calcium increased significantly within 3 d of the restriction of phosphorus intake. Urinary excretion of magnesium did not change significantly in the four patients in whom the measurement was made.
Phosphorus supplementation. When the dietary intake of phosphorus was supplemented for 5 d, the plasma concentration of 1,25-(OH)2D decreased in five ofthe six patients studied from a mean of 30±2 to 20±2 pg/ml (32±7%, P < 0.01) (Table II, Fig. 2) 2. Plasma concentrations of 25-OHD did not change significantly. The serum concentrations of both carboxyl-and intact-iPTH increased in each of the patients; the mean increase for C-iPTH was 73±35 Mleq/ml (131±39%) and for intact-iPTH 97±40 pg/ml (45±17%) (P < 0.05, respectively, by the Wilcoxon signed rank test). After phosphorus had been supplemented for 2 d, the fasting serum concentration of phosphorus increased by a mean of 1.0±0.5 mg/dl; thereafter it decreased, so that after 5 d ofsupplementation the mean value was not significantly different from that during the control period (Table II) . The mean serum concentrations ofcalcium and magnesium did not change significantly during the period of phosphorus supplementation. Both the 24-h total and fractional urinary excretions of phosphorus increased progressively during phosphorus supplementation, and the increase for both was significant after 1 d of supplementation. Total urinary excretions of calcium and magnesium did not change significantly.
When the results obtained with high and low dietary intakes ofphosphorus were analyzed as a single set, the changes induced in the plasma concentration of 1,25-(OH)2D correlated significantly and inversely with the changes induced in serum concentrations of both carboxyl-and intact-iPTH (r = -0.88, P < 0.001, Fig. 3 ). The changes induced in the concentration of 1,25-(OH)2D did not correlate with changes in serum concentrations of calcium, phosphorus, or magnesium, or with changes in total and fractional urinary excretions ofphosphorus. The value of endogenous creatinine clearance was not affected by changes in phosphorus intake in any study of any patient (Table II) .
Discussion
The present study confirms that in children with moderate renal insufficiency in whom dietary intake of phosphorus is not restricted, the mean plasma concentration of 1,25-(OH)2D is significantly lower than that observed in age-matched controls (20) (21) (22) , and the serum concentration of iPTH is increased (21, 22, 37) . In adult patients with chronic renal insufficiency in whom GFR is below 40-50 ml/min, circulating levels of 1,25-(OH)2D have been found to be decreased and to vary in direct proportion with estimated GFR (17-19, 23, 24) . In those adults in whom GFR is -50 ml/min or greater, the values of 1,2540H)2D are normal or even increased (15, 23) . In the present study, the observed increase in C-iPTH may reflect in part re-2. When their phosphorus supplementation studies were performed, 1 and 2 yr, respectively, after their phosphorus restriction studies, two of the five twice-studied patients had become pubescent and were undergoing a somatic growth "spurt". In these two patients the control values of plasma 1,2540H)2D (when dietary phosphorus was normal) had increased by 10 and 13 pg/ml, respectively. The higher values attained accounted for a mean control value of 1,25-(OH)2D that was 4 pg/ml higher in the supplementation study than in the restriction study. In healthy children, the plasma concentration of 1,25-(OH)2D increased strikingly during puberty coincident with the peak in growth velocity (Sa). in serum concentration of (pg/ml) iPTH.
duced renal clearance of biologically inactive fragments of PTH (51) , whereas the increase in intact-iPTH presumably reflects an increase in biologically active hormone (48) . In confirming that restriction of dietary phosphorus can reverse the hyperparathyroidism of patients with moderate renal insufficiency (52), the observations made in the present study, like those made previously in the dog with experimental reduction ofrenal mass (27, (53) (54) (55) , provide further support for the formulation that a normal dietary intake ofphosphorus can pathogenetically determine the hyperparathyroidism characteristic of chronic renal insufficiency (27, (53) (54) (55) .
In patients with moderate renal insufficiency, restriction of dietary phosphorus might prevent or ameliorate secondary hyperparathyroidism by preventing an otherwise predictable if transient increase in the serum concentration of phosphorus that increases the release of PTH by reciprocally decreasing the plasma concentration of ionized calcium (56) . In such patients, the repeatedly observed and currently confirmed decrease in the morning fasting serum concentration of phosphorus (21, 36, 57, 58) might be a consequence of hyperparathyroidism; which is evoked and possibly amplified by earlier postprandial hyperphosphatemia (59) . But in the present study, when the dietary intake of phosphorus was normal in the children with moderate renal insufficiency, the serum concentration of phosphorus was not higher than that of normal control subjects at any time during the day, and the serum concentration of iPTH did not increase after meals in either group of subjects (Fig. 1) . Thus, it would be difficult to infer that in the children with moderate renal insufficiency, the extant hyperparathyroidism is either caused by transient increases in the serum concentration of phosphorus or reversed by prevention of such increases.
The present study demonstrates, however, that in the children with moderate renal insufficiency, restriction of dietary phosphorus for S d not only decreased the serum concentration of intact-iPTH (and C-iPTH) but also increased the mean plasma (31) (32) (33) and the production of 1,25-(OH)2D (60) . In subjects with intact renal function, increased circulating levels of iPTH are predictably attended by increased levels of 1 ,25-(OH)2D (14, (61) (62) (63) , and in patients with primary hyperparathyroidism, the plasma concentration of 1,25-(OH)2D decreased abruptly from greatly increased values to normal values when parathyroid adenomas were surgically removed (64) . In normal adult subjects in whom dietary calcium was either restricted or supplemented, the changes induced in the circulating concentration of iPTH correlated directly with those induced in the concentration of 1,25-(OH)2D (65) .
We would propose that in the currently studied children with moderate renal insufficiency, manipulation of dietary phosphorus induced changes in the plasma concentration of 1,25-(OH)2D that were primary and mediating of, at least in part, the changes observed in the serum concentration ofiPTH. Specifically, by increasing the plasma concentration of 1,25-(OH)2D, phosphorus restriction could have induced an increase in the plasma concentration of ionized calcium by increasing both its intestinal absorption and bone resorption, and thereby could have decreased the release and hence the serum concentration of iPTH. Conversely, by further decreasing the plasma concentration of 1,25-(OH)2D, phosphorus supplementation could have induced the further increase in serum concentration of iPTH. Although plasma-ionized calcium was not measured in the present study, the phosphorus-induced changes in plasma concentration of 1,25-(OH)2D occurred over a range of values found to correlate directly with intestinal absorption of calcium (19, 61) . When hypercalciuria was induced in healthy adult subjects by sodium loading, a 34% increase in serum concentration of 1,25-(OH)2D was attended by a significant increase in intestinal absorption of calcium (66) . That the 60% increase in circulating 1,25- (68) .
The hyperparathyroidism of patients with chronic renal insufficiency may reflect, in part, disordered regulation of secretion of PTH by the plasma concentration of ionized calcium (69, 70) . Although it is unclear whether 1,25-(OH)2D per se can suppress the release ofPTH, the increase in plasma concentration of 1,25-(OH)2D induced in the present studies by phosphorus restriction may have rendered the parathyroid glands more susceptible to suppression by plasma-ionized calcium (71, 72) . If so, the suppressive effect ofan even minimal increase in plasmaionized calcium, one that need not be reflected by an increase in the concentration of total calcium, could be amplified by the observed increase in plasma concentration of 1,25-(OH)2D. Whatever the precise mediating mechanisms, the results of the present study provide support for the hypothesis that in children with moderate renal insufficiency, a normal dietary intake of phosphorus, which is not associated with an increase in serum concentration of phosphorus, entrains a decrease in the plasma concentration of 1,25-(OH)2D that contributes to the pathogenesis of the hyperparathyroidism characteristic of these patients.
In dogs with experimental chronic renal insufficiency, Kaplan et al. (55) Phosphorus is known to be an important determinant of the renal synthesis of 1,25-(OH)2D and thereby of its plasma concentration. In parathyroidectomized, vitamin D-deficient chicks and rats, the activity of 1-hydroxylase (33) and the apparent production of 1,25-(OH)2D (73) varies inversely with the serum concentration of phosphorus. In the intact chick, phosphorus restriction stimulates the activity of 1-hydroxylase (39) , and in the intact rat it increases both the plasma concentration (38, 42) and the renal synthesis (74) of 1,25-(OH)2D. In healthy women, phosphorus restriction induced a 45% increase in the circulating concentration of 1,25-(OH)2D despite a decrease in the concentration of iPTH (41) , and in healthy men it induced an increase in both the serum concentration of 1,25-(OH)2D and in its rate of production (75) . In patients with either idiopathic hypercalciuria (43) or primary hyperparathyroidism (44), supplementation of dietary phosphorus decreased the circulating concentration of 1,25-(OH)2D despite a significant increase in the concentration of iPTH and no increase in the serum concentration of phosphorus. One group of investigators speculated that the increased intake of phosphorus altered renal synthesis of 1,25-(OH)2D by altering either the transcellular flux of phosphorus or its concentration in the renal cell (43). Indeed, it has been proposed that renal synthesis of 1,25-(OH)2D is principally determined by the concentration of inorganic phosphorus in renal cortical cells (73) .
The proximal renal tubule is the principal site of both the renal reabsorption of phosphorus (76) (77) (78) and the activity of l-hydroxylase (9-11). In the currently studied children with moderate renal insufficiency, a normal dietary intake of phosphorus was attended by a greatly increased fractional excretion of phosphorus, which reflected an increased rate of phosphorus excretion per nephron, and presumably an increased delivery ofphosphorus to more distal segments ofthe remaining proximal tubules. An increase in intracellular concentration or transepithelial processing of phosphorus in the proximal tubule might suppress the activity of 1-hydroxylase, and thereby restrict the synthesis of 1,25-(OH)2D, even in the absence of an increased serum level of phosphorus and despite the presence of an increased serum level of iPTH. When the children with moderate renal insufficiency were phosphorus restricted for only 5 
